Related news from
Mon, 13 May 2024 20:30:00 +0000	Integra LifeSciences to Present at the 2024 Bank of America Healthcare Conference PRINCETON, N.J., May 13, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Lea Knight, chief financial officer will present at the 2024 Bank of America Healthcare conference on Tuesday, May 14, 2024 at 4:40pm ET. A live webcast of the presentation will be available on the Integra LifeSciences investor relations website at http://investor.integralife.com/events-and-presentations. About Integra LifeS
Mon, 13 May 2024 16:07:00 +0000	Deciphering Integra (IART) International Revenue Trends Examine the evolution of Integra's (IART) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.
Wed, 08 May 2024 04:15:30 +0000	Integra still addressing problems at Boston plant A third-party audit of the Boston facility identified more issues, forcing Integra to keep Surgimend and Primatrix off the market for the foreseeable future.
Tue, 07 May 2024 15:33:00 +0000	Integra's (IART) Q1 Earnings Match Estimates, Margins Down Strong demand for Integra's (IART) diverse portfolio of leading brands and continued successful market adoption of CereLink contributes to its revenues.
Tue, 07 May 2024 15:10:08 +0000	Integra LifeSciences Holdings Corporation (NASDAQ:IART) Q1 2024 Earnings Call Transcript Integra LifeSciences Holdings Corporation (NASDAQ:IART) Q1 2024 Earnings Call Transcript May 6, 2024 Integra LifeSciences Holdings Corporation misses on earnings expectations. Reported EPS is $-0.04221 EPS, expectations were $0.55. IART isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, […]
Tue, 07 May 2024 07:02:41 +0000	Integra Lifesciences Holdings Corp (IART) Q1 2024 Earnings Call Transcript Highlights: ... Despite mixed financial results, Integra Lifesciences outlines strategic moves and robust international growth in the first quarter of 2024.
Tue, 07 May 2024 05:45:38 +0000	Q1 2024 Integra Lifesciences Holdings Corp Earnings Call Q1 2024 Integra Lifesciences Holdings Corp Earnings Call
Mon, 06 May 2024 17:23:55 +0000	Why Is Medical Device Maker Integra LifeSciences Stock Falling On Monday? Monday, Integra LifeSciences Holdings Corporation (NASDAQ:IART) reported first-quarter revenues of $368.9 million, down 3.1% Y/Y on a reported basis and 2.5% on an organic basis, beating the consensus of $361.96 million and the management guidance of $360 million to $365 million. Revenue increased by 1.6% on an organic basis, excluding Boston. Integra Lifesciences reported an adjusted EPS of $0.55, which is in line with the consensus and lower than $0.74 a year ago. The management had forecasted
Mon, 06 May 2024 13:30:09 +0000	Integra (IART) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates The headline numbers for Integra (IART) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Mon, 06 May 2024 10:29:18 +0000	Integra LifeSciences Q1 Adjusted Earnings, Revenue Fall; Updates 2024 Outlook Integra LifeSciences Q1 Adjusted Earnings, Revenue Fall; Updates 2024 Outlook
Mon, 06 May 2024 10:00:00 +0000	Integra LifeSciences Reports First Quarter 2024 Financial Results PRINCETON, N.J., May 06, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the first quarter ending March 31, 2024. First Quarter 2024 Highlights First quarter revenues of $368.9 million declined 3.1% on a reported basis and declined 2.5% on an organic basis compared to the prior year. Revenue increased 1.6% on an organic basis excluding BostonFirst quarter GAAP earnings per diluted
Tue, 30 Apr 2024 20:20:00 +0000	Integra LifeSciences to Spotlight CereLink® Intracranial Pressure (ICP) Monitoring System at the American Association of Neurological Surgeons (AANS) Annual Scientific Meeting Visit the Codman Specialty Surgical booth to learn how the CereLink ICP Monitoring System provides patients with uncompromised advanced continuous ICP monitoring. CereLink ICP Monitoring Sytem CereLink ICP Monitoring System will be highlighted in booth #655 at AANS Annual Meeting in Chicago, Illinois. PRINCETON, N.J., April 30, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, is pleased to announce that following a su
Thu, 18 Apr 2024 21:24:00 +0000	Integra LifeSciences to Reschedule the First Quarter 2024 Financial Results Conference Call to May 6, 2024 PRINCETON, N.J., April 18, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today announced that it has rescheduled the release of the Company’s first quarter 2024 financial results to Monday, May 6, 2024. In conjunction with the earnings release, Integra’s management team will host a conference call at 8:30 a.m. EDT. A live webcast will be available on the Investors section of the Company’s website at investor.integr
Thu, 18 Apr 2024 14:01:51 +0000	Edwards Lifesciences (EW) Earnings Expected to Grow: What to Know Ahead of Next Week's Release Edwards Lifesciences (EW) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Wed, 17 Apr 2024 14:01:18 +0000	Earnings Preview: Integra LifeSciences (IART) Q1 Earnings Expected to Decline Integra (IART) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Tue, 09 Apr 2024 12:41:00 +0000	Here's Why Investors Should Retain Integra (IART) Stock Now Integra's (IART) strong focus on portfolio optimization and international expansion bolsters investors' confidence in the stock.
Mon, 01 Apr 2024 20:15:00 +0000	Integra LifeSciences Completes the Acquisition of Acclarent, Inc. PRINCETON, N.J., April 01, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced it has successfully completed its acquisition of Acclarent, Inc., a pioneer in ear, nose and throat (ENT) surgical interventions. The addition of Acclarent's innovative product portfolio expands the breadth of Integra’s market-leading brands and provides immediate scale and accretive growth via a dedicated sales channel. The acq
Sun, 31 Mar 2024 14:58:56 +0000	Integra LifeSciences Holdings' (NASDAQ:IART) earnings have declined over three years, contributing to shareholders 48% loss For many investors, the main point of stock picking is to generate higher returns than the overall market. But if you...
Fri, 29 Mar 2024 15:30:33 +0000	Why Is Integra (IART) Down 4% Since Last Earnings Report? Integra (IART) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Wed, 13 Mar 2024 12:17:14 +0000	11 Oversold Healthcare Stocks To Buy Right Now In this article, we will be taking a look at 11 oversold healthcare stocks to buy right now. To skip our detailed analysis of the healthcare sector, you can go directly to see the 5 Oversold Healthcare Stocks To Buy Right Now. The Healthcare Sector: The New 2024 Idea? The healthcare sector has been popular […]